Gene · 6523
Papers3,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sodium-Glucose Transporter 2: Untangling the Mingled Yarn of Genetic and Pharmacologic Inhibition. | Kidney360 | 2025 | 40272970 | PubTator, text mining | PubMed |
| Grain bound polyphenols: Molecular interactions, release characteristics, and regulation mechanisms of postprandial hyperglycemia. | Food Res Int | 2025 | 40263868 | PubTator, text mining | PubMed |
| A Novel, Multifunctional Resistant Starch-Phenol Complex with Potential for Better Glycemic Control. | J Agric Food Chem | 2025 | 40263306 | PubTator, text mining | PubMed |
| Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer. | BMC Gastroenterol | 2025 | 40229676 | PubTator, text mining | PubMed |
| CONSTRUCT: an algorithmic tool for identifying functional or structurally important regions in protein tertiary structure. | Bioinformatics | 2025 | 40220324 | PubTator, text mining | PubMed |
| Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin. | Prog Cardiovasc Dis | 2025 | 40216322 | PubTator, text mining | PubMed |
| Long-term consumption of moderate amounts of sucrose-sweetened drinks disrupts intestinal barrier function by impairing goblet cell differentiation. | Cell Tissue Res | 2025 | 40072586 | PubTator, text mining | PubMed |
| Acute tuft cell ablation in mice induces malabsorption and alterations in secretory and immune cell lineages in the small intestine. | Physiol Rep | 2025 | 40051209 | PubTator, text mining | PubMed |
| Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial. | Lancet Diabetes Endocrinol | 2025 | 39961315 | PubTator, text mining | PubMed |
| Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway. | Adv Sci (Weinh) | 2025 | 39950948 | PubTator, text mining | PubMed |
| Comparison of polysaccharides isolated from Ganpu tea of different storage ages: Chemical, structural, and hypoglycemic properties. | J Food Sci | 2025 | 39921296 | PubTator, text mining | PubMed |
| Exploring genes associated with metabolic dysfunction as therapeutic targets for head and neck cancers: a novel strategy. | Int J Surg | 2025 | 39907620 | PubTator, text mining | PubMed |
| Cardiovascular Outcomes in Patients with Complex Type 2 Diabetes Mellitus Treated with the Dual SGLT Inhibitor Sotagliflozin: A Meta-analysis. | Diabetes Ther | 2025 | 39883288 | PubTator, text mining | PubMed |
Correction: Larsen, E.H.; Sørensen, J.N. Biophysical Analysis of a Minimalistic Kidney Model Expressing SGLT1 Reveals Crosstalk between Luminal and Lateral Membranes and a Plausible Mechanism of Isosmotic Transport. Biomolecules 2024, 14, 889. | Biomolecules | 2025 | 39858547 | PubTator, text mining | PubMed |
| Coffee Pulp from Azores: A Novel Phytochemical-Rich Food with Potential Anti-Diabetic Properties. | Foods | 2025 | 39856971 | PubTator, text mining | PubMed |
| The role of SGLT1 in atrial fibrillation and its relationship with endothelial-mesenchymal transition. | Biochem Biophys Res Commun | 2025 | 39823893 | PubTator, text mining | PubMed |
| Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress. | World J Diabetes | 2025 | 39817219 | PubTator, text mining | PubMed |
| Encapsulation of hydrophobically ion-paired teduglutide in nanoemulsions: Effect of anionic counterions. | Food Chem | 2025 | 39788016 | PubTator, text mining | PubMed |
| Hesperidin inhibits colon cancer progression by downregulating SLC5A1 to suppress EGFR phosphorylation. | J Cancer | 2025 | 39781340 | PubTator, text mining | PubMed |
| The effect of carbohydrates with different levels of digestibility on energy metabolism in vivo under hypobaric hypoxic conditions. | Carbohydr Polym | 2025 | 39779022 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6523/papers?page=7